ASCO 2026 Highlights
Chicago, May 29–June 2, 2026
Past congress.
Top 10 trials to watch
The trials the faculty picked to watch at ASCO 2026, one list per tumor group. Each trial opens its own page.
Breast
10 trials
- Abstract 500OPTIMA
- Abstract LBA1006PERSEVERA BC
- Abstract 507KEYNOTE-522
- Abstract LBA1007SERENA-6
- Abstract 502LIDERA BC
- Abstract LBA1000ASCENT-04
- Abstract 501NATALEE
- Abstract LBA503SENOMAC
- Abstract 1001ASCENT-03
- Abstract LBA1003Izalontamab brengitecan vs physician’s choice chemotherapy in unresectable LA/metastatic TNBC (phase III)